Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
LONDON, March 4 (Reuters) - Britain's medical regulator on Thursday said it would fast-track vaccines for coronavirus variants, adding that the makers of already-authorised shots would not need new lengthy clinical trials to prove their adapted v...
Read moreBy Krishna N. DasNEW DELHI, March 4 (Reuters) - Indian doctors and politicians on Thursday welcomed efficacy data for a state-backed coronavirus vaccine that was given emergency approval in January without the completion of a late-stage trial, m...
Read more(Adds details, other vaccine deals)PRAGUE, March 3 (Reuters) - The Czech Republic has asked China for deliveries of coronavirus vaccines made by China's Sinopharm, the Czech president's spokesman said on Wednesday.The central European country of 10...
Read moreBy Nancy LapidMarch 3 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Immune system T cell responses...
Read more
AstraZeneca vaccine effective in over-80s, English study shows
Read more(Recasts lead with comments by prime minister, adds details, quote, background)OTTAWA, March 3 (Reuters) - Canada is "very optimistic" it can speed up its COVID-19 inoculation program, Prime Minister Justin Trudeau said on Wednesday, a day after W...
Read moreBUDAPEST, March 3 (Reuters) - Hungary plans to extend the use of AstraZeneca's coronavirus vaccine to people older than 60 after data showed its efficacy in the group, Surgeon General Cecilia Muller said on Wednesday as the country ramped up its ...
Read moreBy Alexander WinningJOHANNESBURG, March 3 (Reuters) - Research by South African scientists suggests that antibodies triggered by exposure to the country's dominant coronavirus variant can prevent infection by other variants, the scientists said on...
Read more
(Sharecast News) - Croda International: Berenberg reiterates buy with a target price of 7,400p.
Read more(Updates throughout, adding quotes, background, details)By Kate KellandLONDON, March 3 (Reuters) - British scientists urged European countries to take note on Wednesday of interim data showing what they described as "remarkable" effectiveness of a ...
Read moreBy Francesco Guarascio and Ludwig BurgerBRUSSELS, March 3 (Reuters) - The European Union drug regulator does not see enough evidence yet to recommend changes to the dosage regime for COVID-19 vaccines, despite pressure from EU states after positiv...
Read moreMILAN, March 3 (Reuters) - Some Italian companies have given their availability to produce COVID-19 vaccines and the production could take off in 4-6 months after regulators' authorisation, the industry ministry said on Wednesday.Many companies wo...
Read moreLONDON, March 3 (Reuters) - One dose of either Pfizer-BioNTech's or AstraZeneca's COVID-19 vaccine helps to prevent disease severe enough to require hospitalisation of people in their 80s with other illnesses, interim data from a UK study showed ...
Read more(Adds details, background)BERLIN, March 3 (Reuters) - Germany's vaccine regulator should recommend within days that the AstraZeneca coronavirus vaccine can be given to people older than 65 as evidence mounts of its efficacy, Health Minister Jens S...
Read moreTOP NEWS: US court finds in AstraZeneca's favour in patent litigation
Read more
Last checked at